Ardeparin

Ardeparin
Clinical data
AHFS/Drugs.com	Multum Consumer Information
Routes of; administration	Injection
ATC code	none;
Legal status
Legal status	US: ℞-only / Withdrawn;
Pharmacokinetic data
Bioavailability	92%
Identifiers
	IUPAC name 6-[5-acetylamino-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-3-[5-(6-;
CAS Number	9041-08-1 ;
DrugBank	DB00407 ;
ChemSpider	none;
UNII	N3927D01PB;
ChEMBL	ChEMBL1201448 ;
CompTox Dashboard (EPA)	DTXSID301010914 ;
ECHA InfoCard	100.110.590
Chemical and physical data
Formula	(C26H40N2O36S5)n
Molar mass	5500–6500 g/mol (average)
	(what is this?) (verify)

Ardeparin (trade name Normiflo) is an anticoagulant. It was used for the prevention of deep vein thrombosis, but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy.[1][2][3]

References

Frishman WH, Cheng-Lai A, Chen J (2000). "Antithrombotic therapy". Current cardiovascular drugs (3rd ed.). Philadelphia, Pa.: Current Medicine. p. 90. ISBN 978-1-4615-6767-7.
"Normiflo". Drugs.com. Archived from the original on 2017-02-19. Retrieved 2018-01-23.
"Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness". United States Food and Drug Administration. Federal Register. Retrieved 24 June 2022.

External links

"Heparin sodium". Drug Information Portal. U.S. National Library of Medicine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Frishman WH, Cheng-Lai A, Chen J (2000). "Antithrombotic therapy". Current cardiovascular drugs (3rd ed.). Philadelphia, Pa.: Current Medicine. p. 90. ISBN 978-1-4615-6767-7.

[2] "Normiflo". Drugs.com. Archived from the original on 2017-02-19. Retrieved 2018-01-23.

[3] "Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness". United States Food and Drug Administration. Federal Register. Retrieved 24 June 2022.